Stroke and TIA

Aug 1, 2001 Issue
American Heart Association Scientific Statement on the Primary Prevention of Ischemic Stroke [Practice Guidelines]

The American Heart Association (AHA) has issued a scientific statement on the primary prevention of ischemic stroke. The scientific statement includes an overview of established and potential risk factors and recommendations.

Jan 15, 2000 Issue
When to Operate in Carotid Artery Disease [Article]

Carotid endarterectomy has proved to be beneficial in the prevention of stroke in selected patients. The procedure is indicated in symptomatic patients with carotid-territory transient ischemic attacks or minor strokes who have carotid artery stenosis of 70 to 99 percent. With a low surgical risk, c...

Nov 15, 1999 Issue
Preventing Stroke in Patients with Transient Ischemic Attacks [Article]

Stroke is the third most common overall cause of death and the leading cause of adult disability in the United States. New therapeutic interventions instituted in the period immediately after a stroke have revolutionized the approach to ischemic cerebrovascular disease. Recognition of a transient is...

May 15, 1999 Issue
Stroke: Part II. Management of Acute Ischemic Stroke [Article]

Optimal treatment of the patient who has sustained an acute ischemic stroke requires rapid assessment and early intervention. The leisurely approach to acute stroke management sometimes taken in the past should be replaced by an approach that treats stroke as a true medical emergency. Thrombolysis w...

May 1, 1999 Issue
Stroke: Part I. A Clinical Update on Prevention [Article]

Clinical trials conducted during the past five years have yielded important results that have allowed us to refine our approach to stroke prevention. Treatment of isolated systolic hypertension prevents stroke and is generally well tolerated. New antiplatelet agents (clopidogrel and the combination ...

Jan 1, 1998 Issue
Practical Considerations in the Early Treatment of Ischemic Stroke [Article]

Successful treatment of patients with ischemic stroke depends on the ability to treat within three hours of onset, because tissue plasminogen activator has not yet been proved effective beyond this time frame. The two major causes of delay in treatment are failure, on the part of the patient or fami...

Pages: Previous 1 2 3 4 5 6 7

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now